###begin article-title 0
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia
###end article-title 0
###begin p 1
I. Plo and Y. Zhang contributed equally to this paper.
###end p 1
###begin p 2
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
###xml 735 740 735 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
###xml 650 657 <span type="species:ncbi:9606">patient</span>
We identify an autosomal mutation in the CSF3R gene in a family with a chronic neutrophilia. This T617N mutation energetically favors dimerization of the granulocyte colony-stimulating factor (G-CSF) receptor transmembrane domain, and thus, strongly promotes constitutive activation of the receptor and hypersensitivity to G-CSF for proliferation and differentiation, which ultimately leads to chronic neutrophilia. Mutant hematopoietic stem cells yield a myeloproliferative-like disorder in xenotransplantation and syngenic mouse bone marrow engraftment assays. The survey of 12 affected individuals during three generations indicates that only one patient had a myelodysplastic syndrome. Our data thus indicate that mutations in the CSF3R gene can be responsible for hereditary neutrophilia mimicking a myeloproliferative disorder.
###end p 2
###begin p 3
###xml 166 193 166 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">de la Chapelle et al., 1993</xref>
###xml 195 217 195 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Kralovics et al., 1997</xref>
###xml 219 236 219 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Ding et al., 2004</xref>
###xml 316 337 316 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Wiestner et al., 1998</xref>
###xml 864 893 864 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Panopoulos and Watowich, 2008</xref>
###xml 990 995 990 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
Hereditary erythrocytosis and thrombocytosis with an autosomal-dominant pattern are linked to mutations in the erythropoietin or thrombopoietin (TPO; MPL) receptors (de la Chapelle et al., 1993; Kralovics et al., 1997; Ding et al., 2004), respectively, or to a dysregulation of the synthesis of these two cytokines (Wiestner et al., 1998). These syndromes differ from classical myeloproliferative disorders (MPDs) by the low incidence of early and late complications. They recapitulate the chronic administration of recombinant growth factors (i.e., TPO and erythropoietin). The G-CSF receptor (G-CSF-R) is also a type I cytokine receptor that binds G-CSF, the main cytokine that regulates granulopoiesis. G-CSF-R activation by G-CSF not only induces proliferation and differentiation of neutrophils but also mobilizes BM hematopoietic progenitors cells to blood (Panopoulos and Watowich, 2008). In this report, we identified a familial chronic neutrophilia caused by an autosomal-dominant CSF3R gene mutation that constitutively activates G-CSF-R.
###end p 3
###begin title 4
RESULTS AND DISCUSSION
###end title 4
###begin p 5
###xml 64 72 64 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 494 495 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 634 635 634 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 747 750 747 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcr</italic>
###xml 751 754 751 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abl</italic>
###xml 775 780 775 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V617F</sup>
###xml 771 780 771 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAK2<sup>V617F</sup></italic>
###xml 1048 1049 1048 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1072 1073 1072 1073 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1486 1490 1486 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EVI1</italic>
###xml 1506 1526 1506 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">De Melo et al., 2008</xref>
###xml 1574 1578 1574 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EVI1</italic>
###xml 1649 1653 1649 1653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EVI1</italic>
###xml 231 238 <span type="species:ncbi:9606">patient</span>
###xml 820 827 <span type="species:ncbi:9606">patient</span>
We studied a three-generation Caucasian pedigree (aged 8-80 yr; Fig. 1 A) in which 12 out of 16 individuals (6 males and 6 females) presented with a chronic neutrophilia associated with splenomegaly. The disorder was discovered in patient 15 during a unique episode of systemic inflammatory response syndrome that combined fever, tachycardia, dyspnea, pleural and pericardial effusion, hepatosplenomegaly, and weight loss. Biological features associated increased WBC counts by 102,000 cells/mm3, with 75% segmented neutrophils and 20% immature granulocytes, the hemoglobin level by 10 g/dl, and the platelet count by 101,000 cells/mm3. BM analysis revealed an increase in granulocyte precursors without an excess of blasts. Karyotype was normal. Bcr-Abl transcripts and JAK2V617F were not detected. After this episode, patient 15 returned to chronic neutrophilia, but 18 mo later, he developed a myelodysplastic syndrome (refractory anemia with an excess of blasts type I) associating pancytopenia (hemoglobin, 8.1 g/dl; platelets, 41,000 cells/mm3; 800 polymorphs per mm3 along with 12% of circulating immature granulocytes), skin infiltration by mature granulocytes, and 9% BM blasts. BM aspirate examination also showed a marked dysgranulopoiesis but no dyserythropoiesis or dysmegakaryopoiesis. A clonal abnormality (del 3q26) was detected by a conventional cytogenetic in 70% of the metaphases (14 out of 20). A fluorescent in situ hybridization analysis did not show evidence of EVI1 rearrangement (De Melo et al., 2008). To eliminate a transcriptional activation of EVI1, we performed quantitative real-time PCR (qRT-PCR). A 30% decrease in EVI1 mRNA was detected (), suggesting that the deletion includes this gene.
###end p 5
###begin p 6
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">An inherited mutation in the <italic>CSF3R</italic> gene in a familial neutrophilia.</bold>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 606 607 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 626 627 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 925 926 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 945 946 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1157 1158 1155 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 411 419 <span type="species:ncbi:9606">patients</span>
###xml 480 487 <span type="species:ncbi:9606">patient</span>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
###xml 633 641 <span type="species:ncbi:9606">patients</span>
###xml 715 722 <span type="species:ncbi:9606">patient</span>
###xml 935 943 <span type="species:ncbi:9606">patients</span>
###xml 952 960 <span type="species:ncbi:9606">patients</span>
###xml 1032 1039 <span type="species:ncbi:9606">patient</span>
###xml 1145 1152 <span type="species:ncbi:9606">patient</span>
###xml 1302 1309 <span type="species:ncbi:9606">patient</span>
An inherited mutation in the CSF3R gene in a familial neutrophilia. (A) Pedigree of the family. The black symbols represent affected individuals with neutrophilia and T617N amino acid substitution. The gray symbols represent individuals for whom clinical information was not available. The white symbols represent nonaffected individuals. The genotype is also indicated (N/N, normal subjects; N/M, heterozygous patients). (B) Examples of electrophoregrams from normal subjects or patient 15 DNA (T617N). (C-E) Liquid culture of CD34+ cells in the presence of SCF plus G-CSF or SCF (C and D) from controls (n = 5) or patients (n = 2, patients 7 and 15) in which three independent experiments were performed for each patient. Error bars represent means +/- SD. *, P < 0.05. (E) Cytological examination at day 21 of culture. Numbers indicate the percentages of mature granulocytic cells. Results are representative of controls (n = 3) or patients (n = 2, patients 7 and 15) in which two independent experiments were performed for each patient. (F) Western blot analysis of P-Jak2, P-STAT3, P-STAT5, P-ERK p42-p44, and P-AKT antibodies in normal or patient CD34+ cells stimulated by G-CSF in the presence or not of AZ1480. Results are representative of three independent experiments either with control or patient 15. Black lines indicate that intervening lanes have been spliced out.
###end p 6
###begin p 7
###xml 193 194 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 225 226 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 372 373 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 404 405 404 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 495 496 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 517 524 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 674 677 674 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcr</italic>
###xml 678 681 678 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abl</italic>
###xml 702 707 702 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V617F</sup>
###xml 698 707 698 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAK2<sup>V617F</sup></italic>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
###xml 740 748 <span type="species:ncbi:9606">patients</span>
###xml 756 763 <span type="species:ncbi:9606">patient</span>
Familial history showed that 12 out of 16 members had a chronic neutrophilia. There was no evidence of consanguinity in this pedigree. In the 12 patients, median WBC counts were 21,350 cells/mm3 (range: 14,900-32,800 cells/mm3) in peripheral blood, with >70% segmented neutrophils or band cells and <10% immature granulocytes. Median neutrophil counts were 16,900 cells/mm3 (range: 11,000-23,700 cells/mm3). In the peripheral blood, a 3- to 20-fold increase in the percentage of circulating CD34+ cells was observed (Table I). The BM of two analyzed affected individuals contained an increase in granulocyte precursors without an excess of blasts. The karyotype was normal; Bcr-Abl transcripts and JAK2V617F were not detected. All affected patients except patient 15 had no clinical symptoms.
###end p 7
###begin p 8
Laboratory hematological values from the family members
###end p 8
###begin p 9
NS, not studied.
###end p 9
###begin p 10
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
###xml 484 492 484 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 655 663 655 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 879 884 879 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 874 884 874 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>T617N</sup></italic>
###xml 1007 1026 1007 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Forbes et al., 2002</xref>
###xml 1168 1187 1168 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Forbes et al., 2002</xref>
###xml 1234 1239 1234 1239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 1229 1239 1229 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>T617N</sup></italic>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 742 745 <span type="species:ncbi:9606">men</span>
###xml 749 754 <span type="species:ncbi:9606">women</span>
###xml 969 977 <span type="species:ncbi:9606">patients</span>
Based on the autosomal-dominant pattern of inheritance of the disorder and the high level of blood CD34+ cells, we tested the hypothesis that neutrophilia in this family resulted from activation of the G-CSF-R signaling. Because G-CSF concentration in the serum (two patients studied) was below the detection limit (<39 pmol/ml), we sequenced the CSF3R gene. We found a heterozygous C-to-A substitution at nucleotide 2,088 that leads to a threonine-to-asparagine substitution (T617N; Fig. 1 B). This heterozygous point mutation was observed in the 12 affected individuals but not in the 4 healthy family members, and was segregated with the neutrophilia (Fig. 1 A). Moreover, the mutation was found in all generations and in as many affected men as women. Finally, the mutation was transmitted with an autosomal-dominant pattern of inheritance with complete penetrance. The CSF3RT617N mutation has already been described as an activating mutation found in 2 out of 555 patients with acute myeloid leukemia (Forbes et al., 2002). In these two cases, the mutation was acquired because it disappeared after complete remission achievement and was not detected at relapse (Forbes et al., 2002). This last result demonstrates that the CSF3RT617N mutation was a secondary event in the leukemic process. We studied whether this mutation could be found in sporadic cases of unexplained neutrophilia and investigated 40 cases by allele-specific PCR, but we did not find any other positive case suggesting that this activating mutation is rare.
###end p 10
###begin p 11
###xml 11 16 11 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 4 16 4 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G-CSF-R<sup>T617N</sup></italic>
###xml 109 114 109 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S505N</sup>
###xml 106 114 106 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MPL<sup>S505N</sup></italic>
###xml 180 197 180 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Ding et al., 2004</xref>
###xml 199 220 199 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Chaligne et al., 2008</xref>
###xml 395 413 395 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Adams et al., 1996</xref>
###xml 810 816 810 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
The G-CSF-RT617N mutation is located in the transmembrane (TM) domain of the receptor, analogously to the MPLS505N mutation associated with hereditary or acquired thrombocythemia (Ding et al., 2004; Chaligne et al., 2008). To evaluate the influence of the T617N mutation on TM helix interactions in the G-CSF-R, conformational searches were performed to identify low energy dimer conformations (Adams et al., 1996). For the wild-type G-CSF-R sequence, the lowest energy dimer structure that emerged from the searches had a symmetric orientation of the TM helices with Thr617 in the interface. The lowest energy structures of T617N G-CSF-R dimers had the same helix orientation, but with substantially lower interaction energies (wild-type, approximately -69 kcal/mol; T617N mutant, approximately -81 kcal/mol; Fig. 2). These computational data strongly support the notion that Asn617 stabilizes an active dimeric orientation for G-CSF-R by forming interhelical hydrogen bonds.
###end p 11
###begin p 12
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Computational searches of wild-type and T617N G-CSF-R dimers.</bold>
Computational searches of wild-type and T617N G-CSF-R dimers. (A) Molecular structure of the helix dimer of the T617N mutant having the overall lowest energy in the computational searches. The helices have a left-handed crossing angle and an axial separation of 10.5 A. The interfacial amino acids are highlighted. (B) Plot of the helix interaction energies in the wild-type (black) and T617N (red) TM helix dimers with axial separations of 10.5 A. In the wild-type G-CSF-R, the dominant interaction is a direct Thr617-Thr617 hydrogen bond between side chain hydroxyl groups. In contrast, there are several strong stabilizing interactions in the mutant. The Asn amide side chain forms hydrogen bonds to the thiol side chain of Cys620. Trp624 forms stabilizing van der Waals contacts with the opposing helix; the indole NH is also able to form an interhelical H bond with Cys620. The total interaction energies were very similar for the lowest energy T617N dimers in computational searches at 10 A (-80.6 kcal/mol) and 10.5 A (-81.0 kcal/mol). (C) Cross section of the T617N helix dimer showing hydrogen-bonding interactions involving Thr617 and Cys620. The axial separation is 10.5 A. (D) Cross section of the T617N helix dimer with an axial separation of 11 A stabilized by interhelical interactions between Asn617 side chains and between Asn617 and Cys618. The overall interaction energies were generally higher at longer interhelical separations for both the wild-type and mutant dimers, although the T617N dimers were consistently lower in energy than those of the wild-type dimers because of the ability of Asn617 to form interhelical hydrogen bonds.
###end p 12
###begin p 13
###xml 45 50 45 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 141 142 141 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 395 396 395 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 467 475 467 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 538 539 538 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 547 555 547 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 639 640 639 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 818 826 818 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 991 999 991 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 1054 1059 1054 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 310 318 <span type="species:ncbi:9606">patients</span>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
###xml 452 459 <span type="species:ncbi:9606">patient</span>
###xml 526 533 <span type="species:ncbi:9606">patient</span>
###xml 888 896 <span type="species:ncbi:9606">patients</span>
To determine the impact of the mutant G-CSF-RT617N on G-CSF sensitivity, we measured granulocytic proliferation and differentiation from CD34+ cells in in vitro experiments. In the presence of stem cell factor (SCF) and G-CSF, proliferation was not significantly different between normal subjects and affected patients (patients 7 and 15). In contrast, SCF alone induced survival of control CD34+ cells, whereas it elicited proliferation (4.3-fold) on patient cells (Fig. 1 C). We also observed a hypersensitivity to G-CSF of patient CD34+ cells (Fig. 1 D) that was confirmed by clonogenic assays in methylcellulose (). Moreover, when CD34+ cells from normal subjects and affected individuals were grown in the presence of G-CSF, cells differentiated into mature granulocytes, as indicated by cytological examination (Fig. 1 E). In contrast, in the presence of SCF alone, only cells from patients acquired the terminal granulocytic CD11b antigen () and matured into neutrophilic polymorphs (Fig. 1 E). Collectively, these results show that mutant G-CSF-RT617N induces a G-CSF-independent granulocytic proliferation and differentiation.
###end p 13
###begin p 14
###xml 75 76 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 F</xref>
###xml 777 782 777 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V617F</sup>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
###xml 297 304 <span type="species:ncbi:9606">patient</span>
###xml 579 587 <span type="species:ncbi:9606">patients</span>
To investigate the effects of the T617N mutation on G-CSF-R signaling, CD34+ cells isolated from normal donors or patients were first deprived of cytokines, and then stimulated with G-CSF for various periods of time and subjected to Western blot analysis using specific antibodies. Interestingly, patient cells exhibited constitutive phosphorylation of JAK2, STAT3, AKT, and ERK. After G-CSF stimulation, JAK2, STAT3, STAT5, ERK, and AKT were rapidly and transiently activated in cells from normal donors, whereas phosphorylation was much more potent and sustained in cells from patients (Fig. 1 F). In addition, a specific JAK2 inhibitor abrogated constitutive and G-CSF-induced activation, suggesting that the mechanism of neutrophilia was JAK2 dependent, reminiscent of JAK2V617F MPD.
###end p 14
###begin p 15
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 81 83 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>wt</sup></italic>
###xml 92 97 92 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 87 97 87 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>T617N</sup></italic>
###xml 249 254 249 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 414 436 414 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, A, B, E, and F</xref>
###xml 512 527 512 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, C and D</xref>
###xml 549 550 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 693 698 693 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 877 882 877 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 872 882 872 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>T617N</sup></italic>
###xml 912 920 912 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 G</xref>
###xml 1175 1176 1175 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1366 1367 1366 1367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1489 1490 1489 1490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1540 1548 1540 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 1683 1684 1683 1684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1692 1700 1692 1700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 1754 1762 1754 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1790 1809 1790 1809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Bhatia et al., 1997</xref>
###xml 1811 1827 1811 1827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Ito et al., 2002</xref>
###xml 1829 1851 1829 1851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Matsumura et al., 2003</xref>
###xml 1980 1998 1980 1998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">James et al., 2008</xref>
###xml 2064 2065 2064 2065 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2289 2297 2289 2297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 2345 2350 2345 2350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 2575 2580 2575 2580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 2570 2580 2570 2580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>T617N</sup></italic>
###xml 2688 2709 2688 2709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">McLemore et al., 1998</xref>
###xml 2711 2727 2711 2727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Liu et al., 2008</xref>
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
###xml 191 195 <span type="species:ncbi:10090">Mice</span>
###xml 883 887 <span type="species:ncbi:10090">mice</span>
###xml 1034 1042 <span type="species:ncbi:9606">patients</span>
###xml 1100 1105 <span type="species:ncbi:9606">human</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1217 1224 <span type="species:ncbi:9606">patient</span>
###xml 1356 1361 <span type="species:ncbi:9606">human</span>
###xml 1377 1382 <span type="species:ncbi:10090">mouse</span>
###xml 1477 1484 <span type="species:ncbi:9606">patient</span>
###xml 1648 1652 <span type="species:ncbi:10090">mice</span>
###xml 1671 1678 <span type="species:ncbi:9606">patient</span>
###xml 1936 1940 <span type="species:ncbi:10090">mice</span>
###xml 2018 2023 <span type="species:ncbi:9606">human</span>
###xml 2079 2083 <span type="species:ncbi:10090">mice</span>
###xml 2099 2106 <span type="species:ncbi:9606">patient</span>
###xml 2260 2267 <span type="species:ncbi:9606">patient</span>
###xml 2283 2287 <span type="species:ncbi:10090">mice</span>
###xml 2413 2417 <span type="species:ncbi:10090">mice</span>
We next infected mouse lineage (Lin-) BM cells with a retrovirus containing CSF3Rwt or CSF3RT617N mutation or the empty vector (Migr), and engrafted the infected cells into irradiated hosts. Mice transplanted with cells expressing the mutant G-CSF-RT617N developed neutrophilia and displayed a high percentage of Gr-1+ granulocytes both in blood (33% in T617N vs. 15% in WT) and spleen (31% in T617N vs. 6% in WT; Fig. 3, A, B, E, and F), whereas the percentage of granulocytes in BM was only slightly affected (Fig. 3, C and D). An increase in B220+ B cells was also observed in the spleen, which may be caused by an increase in lymphopoiesis mediated by the ectopic expression of the G-CSF-RT617N after retroviral transduction in hematopoietic stem cells (HSCs). Alternatively, this might be related to cytokine release in the spleen by the granulocytic precursors. All CSF3RT617N mice developed splenomegaly (Fig. 3 G). These data demonstrate that the T617N mutation in the G-CSF-R is at the origin of the neutrophilia observed in patients. To directly assess the consequences of this mutation on human HSCs, we performed xenotransplantation in irradiated NOG mice of CD34+ cells isolated either from the blood of patient 15 or from a G-CSF-mobilized normal donor. At week 15 after transplant, the level of engraftment was measured by the percentage of human CD45+ cells in mouse blood, BM, spleen, and thymus. Levels of chimerism were lower in the four organs studied when patient CD34+ cells were injected compared with control cells (Fig. 4 A). Conversely, myeloid cells represented the predominant population in the blood, BM, and spleen of mice transplanted with patient CD34+ cells (Fig. 4 B), whereas B cells were prevalent with control cells (Fig. 4 C), as previously described (Bhatia et al., 1997; Ito et al., 2002; Matsumura et al., 2003). This skewed differentiation of HSCs to myeloid differentiation in immunodeficient mice has previously been described in MPDs (James et al., 2008). The frequency of human myeloid progenitors found among the CD45+ in the BM of mice engrafted with patient cells was increased in comparison to control cells. Moreover, a marked increase in the content of hematopoietic progenitors was observed in the blood of patient cell-engrafted mice (Fig. 4 D). Collectively, these results show that G-CSF-RT617N mutant not only skews cells to myeloid differentiation in NOG mice but also induces a mobilization of hematopoietic progenitors. Thus, in contrast to the truncating mutations found in severe congenital neutropenia, the CSF3RT617N mutation does not confer a major HSC-proliferative advantage but rather increases myeloid differentiation (McLemore et al., 1998; Liu et al., 2008).
###end p 15
###begin p 16
###xml 5 10 5 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>T617N</sup></italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>CSF3R<sup>T617N</sup></italic> mutation yields to MPD in the mouse BM transplant model.</bold>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 309 311 309 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 304 311 304 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>wt</sup></italic>
###xml 321 326 321 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 316 326 316 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>T617N</sup></italic>
###xml 566 567 566 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 589 590 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 614 615 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 639 640 639 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 735 739 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Migr</italic>
###xml 755 760 755 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
###xml 760 762 760 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 783 788 783 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
###xml 788 793 788 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 647 652 <span type="species:ncbi:10090">mouse</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 951 955 <span type="species:ncbi:10090">mice</span>
CSF3RT617N mutation yields to MPD in the mouse BM transplant model. BM cells were collected from C57/B6 SJL (CD45.2) mice 2 d after 5-fluorouracil treatment. Lin- cells were purified; cultured for 2 d with IL-3, SCF, IL-6, and TPO; infected twice with the viral particles containing empty vector (Migr), CSF3Rwt, or CSF3RT617N; and finally injected intravenously into lethally irradiated (825 rad) C57BL6 (CD45.1) mice. After 5 wk, mice were sacrificed and the total number of cells (A, C, and E) or the percentage of cells (B, D, and F) including granulocytes (Gr-1+), B lymphocytes (B220+), or T lymphocytes (CD3+) was measured in CD45.2+ donor mouse cells in the blood (A and B), BM (C and D), and spleen (E and F). (G) Spleen from Migr-engrafted (I), CSF3Rwt-engrafted (II), and CSF3RT617N-engrafted (III) mice. The results are the means +/- SD of four mice of each group from two independent experiments. *, P < 0.05 compared with Migr-engrafted mice.
###end p 16
###begin p 17
###xml 5 10 5 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>T617N</sup></italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>CSF3R<sup>T617N</sup></italic> mutation yields to MPD in the xenotransplantation model.</bold>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 355 356 355 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 558 559 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 212 217 <span type="species:ncbi:9606">human</span>
###xml 259 264 <span type="species:ncbi:9606">human</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 473 480 <span type="species:ncbi:9606">patient</span>
###xml 581 588 <span type="species:ncbi:9606">patient</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
CSF3RT617N mutation yields to MPD in the xenotransplantation model. CD34+ cells from normal subjects or from patients were intravenously injected into NOG mice and sacrificed at 15 wk. Flow cytometry analysis of human cell engraftment shows the percentage of human CD45+ cells (A) and percentage of B (CD19+) and myeloid (CD33+) cells (B and C) among CD45+ cells in the peripheral blood, BM, spleen, and thymus. The results are the means +/- SD of four mice for donors and patient from two independent experiments. (D) Peripheral blood progenitors among CD45+ cells from donor- or patient-engrafted mice.
###end p 17
###begin p 18
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
###xml 642 667 642 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Germeshausen et al., 2007</xref>
###xml 669 685 669 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Liu et al., 2008</xref>
###xml 749 754 749 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T617N</sup>
###xml 744 754 744 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R<sup>T617N</sup></italic>
###xml 434 442 <span type="species:ncbi:9606">patients</span>
In conclusion, the family described in this report is the first case of germline CSF3R mutation leading to a chronic neutrophilia and mobilization of hematopoietic progenitors, a phenotype similar to that induced by administration of rhG-CSF. The T617N TM mutation induces both proliferation and granulocytic differentiation. Progression to a myelodysplastic syndrome (RAEB I) malignant hemopathy was observed on 1 out of 12 affected patients. The precise role of the acquired CSF3R mutations found in severe congenital neutropenia is not completely resolved. Nevertheless, their association with leukemic progression is increasingly strong (Germeshausen et al., 2007; Liu et al., 2008). Therefore, more investigations are necessary to know if CSF3RT617N mutation predisposes to malignant myeloid hemopathies.
###end p 18
###begin title 19
MATERIALS AND METHODS
###end title 19
###begin title 20

###end title 20
###begin title 21
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient cells.
###end title 21
###begin p 22
###xml 19 27 <span type="species:ncbi:9606">patients</span>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 285 292 <span type="species:ncbi:9606">patient</span>
Blood samples from patients, normal subjects, and G-CSF-mobilized patients were collected after informed consent was obtained. The study was approved by the Local Research Ethics Committee from the Hotel-Dieu and the Henri Mondor hospitals, and informed consent was obtained from each patient in accordance with the Declaration of Helsinki.
###end p 22
###begin title 23
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Purification and in vitro differentiation of CD34+ cells.
###end title 23
###begin p 24
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 593 598 <span type="species:ncbi:9606">human</span>
Mononuclear cells were separated over a Ficoll density gradient, and CD34+ cells were purified by a double-positive magnetic cell sorting system (AutoMACS; Miltenyi Biotec) according to manufacturer's recommendations. CD34+ cells were either plated for 15 d in methylcellulose (StemCell Technologies Inc.) in the presence of 25 ng/ml SCF and G-CSF, or amplified for 21 d in granulocytic conditions in serum-free liquid medium containing IMDM with penicillin/streptomycin/glutamine, alpha-thioglycerol, BSA, a mixture of sonicated lipids, and insulin-transferrin in the presence of recombinant human cytokines (25 ng/ml SCF and 20 ng/ml G-CSF).
###end p 24
###begin title 25
Western blot analysis.
###end title 25
###begin p 26
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
After purification, CD34+ cells were deprived in IMDM alone for 4 h in the presence or not of JAK2 inhibitor (AZD1480) at 1 microM. AZD1480 was a gift from AstraZeneca (Waltham, MA). Cells were stimulated by 20 ng/ml G-CSF for different intervals, washed in PBS, and lysed in denaturing loading dye buffer. Western blot analysis was performed using conventional techniques using anti-Jak2 (pY1007/1008), anti-STAT3 (pY705), anti-STAT5 (pY705), anti-ERK p42-p44 (T202/Y204), and anti-AKT (S473) antibodies (Cell Signaling Technology), and anti-beta-actin antibodies. Antibodies were visualized using the enhanced chemoluminescence detection kit (GE Healthcare).
###end p 26
###begin title 27
DNA sequencing.
###end title 27
###begin p 28
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSF3R</italic>
Genomic DNAs were isolated from mononuclear cells or granulocytes according to standard procedures. Each of the 17 exons of the CSF3R gene (available from GenBank/EMBL/DDBJ under accession no. ) was amplified using standard PCR conditions from 300 ng of genomic DNA and primer sequences derived from flanking intronic sequences. PCR products were filtration purified (Multiscreen PCR; Millipore), sequenced using the BigDye Terminator cycle sequencing ready reaction kit (Applied Biosystems) according to the manufacturer's protocol, and analyzed on an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems).
###end p 28
###begin title 29
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Generation of CSF3R mutant retroviruses and in vivo reconstitution of mouse hematopoietic system.
###end title 29
###begin p 30
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
A human hemagglutinin-tagged full-length CSF3R open reading frame was cloned the in pMIGR-IRES-GFP retroviral vector. Mutagenesis reactions for human CSF3R were performed using the QuickChange site-directed mutagenesis kit (Agilent Technologies). All constructs were verified by sequencing.
###end p 30
###begin p 31
###xml 0 26 <span type="species:ncbi:11276">Vesicular stomatitis virus</span>
Vesicular stomatitis virus glycoprotein-pseudotyped viral particles of pMIGR-IRES-GFP (empty vector), pMIGR-CSF3R-IRES-GFP, and pMIGR-T617N-CSF3R-IRES-GFP were produced into the 293 EBNA cells. Ecotropic virus-producing cell lines were generated from infection of the GP+E-86 packaging cell line (supplied by A. Bank, Columbia University, New York, NY) with concentrated virus supernatants.
###end p 31
###begin p 32
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
BM (Lin-) cells were collected from C57BL/6 SJL (CD45.2) mice (Charles River Laboratories) 2 d after 5-fluorouracil treatment. Lin- cells were purified; cultured for 2 d with IL-3, SCF, IL-6, and TPO; and infected twice with the viral particles and finally injected intravenously into lethally irradiated (8.25 Gy) C57BL/6 (CD45.1) mice.
###end p 32
###begin p 33
Hemoglobin, mean corpuscular volume, hematocrit, RBC, platelet, and WBC counts, and the lymphocyte/granulocyte ratio were determined using an automated counter (MS9; Schloessing Melet) on blood collected from the retro-orbital plexus in citrated tubes. BM cells were removed by flushing two femurs and two tibias. Spleens were weighed and single-cell suspensions were prepared. Differential cell counts were performed after May-Grunwald-Giemsa staining of blood smears or spleen and BM cell cytospins.
###end p 33
###begin title 34
###xml 4 8 <span type="species:ncbi:10090">mice</span>
NOG mice repopulation assays.
###end title 34
###begin p 35
###xml 55 58 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 213 229 209 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Ito et al., 2002</xref>
###xml 236 237 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 461 462 457 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 280 288 <span type="species:ncbi:9606">patients</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 372 377 <span type="species:ncbi:9606">Human</span>
###xml 439 444 <span type="species:ncbi:9606">human</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
24 h before transplantation, 6-8-wk-old NOD/SCID/gammac-/- (NOG) mice, provided by M. Ito (Central Institute for Experimental Animals, Kawasaki, Japan), were sublethally irradiated (3 Gy) as previously described (Ito et al., 2002). CD34+ cells from G-CSF-mobilized donors or from patients were intravenously injected into NOG mice without any administration of cytokines. Human cell engraftment was assessed by flow cytometry by measuring human leukocytes (CD45+). Blood was lysed. BM cells were removed by flushing both femurs. Spleens were weighed and single-cell suspensions were prepared. NOG mice were bred in our pathogen-free breeding facility (Service Centrale d'Experimentation Animale).
###end p 35
###begin p 36
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 94 101 <span type="species:ncbi:9606">patient</span>
###xml 313 318 <span type="species:ncbi:9606">human</span>
###xml 354 359 <span type="species:ncbi:9606">human</span>
For progenitor assay, 50 microl of peripheral blood and BM from mice engrafted with donors or patient cells were seeded in methylcellulose, and progenitors were counted after 14 d in the presence of a cocktail of cytokines (100 IU/ml IL-3, 25 ng/ml SCF, 3 IU/ml erythropoietin, and 5 ng/ml GM-CSF). The number of human colonies was normalized to 100,000 human cells.
###end p 36
###begin title 37
FACS analysis.
###end title 37
###begin p 38
###xml 168 173 <span type="species:ncbi:9606">human</span>
Flow cytometry was used to determine GFP expression and cell content of blood, BM, and spleen cells with appropriate PE- or allophycocyanin-conjugated antibodies (anti-human CD45, anti-CD45.1, anti-CD45.2, anti-CD19, anti-CD3, anti-CD33, anti-CD11b, anti-CD15, anti-CD14, anti-CD34, anti-CDB220, and anti-Gr-1 antibodies; BD) using a cytometer (FACSsort) with the Cell Quest software package (BD).
###end p 38
###begin title 39
Modeling the effect of the T617N mutation on G-CSFR structure and dimerization.
###end title 39
###begin p 40
###xml 96 114 96 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Adams et al., 1996</xref>
###xml 484 504 468 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Seubert et al., 2003</xref>
Computational searches for low energy dimer conformations were performed using the program CHI (Adams et al., 1996). Canonical helices were constructed from the TM sequence of the G-CSF-R (IILGLFGLLLLLTCLCGTAWLCC). Low energy conformations of helix dimers were searched by rotating each helix through rotation angles phi1 and phi2 from 0-360degrees, with a sampling size of 45degrees for axial separations between TM helices of 9.5, 10, 10.5, 11, and 11.5 A, as described previously (Seubert et al., 2003).
###end p 40
###begin title 41
Online supplemental material.
###end title 41
###begin p 42
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EVI1</italic>
###xml 142 163 142 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Vinatzer et al., 2003</xref>
###xml 182 183 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 231 239 <span type="species:ncbi:9606">patients</span>
###xml 430 438 <span type="species:ncbi:9606">patients</span>
Fig. S1 shows qRT-PCR of EVI1 using the Taqman gene expression master mix (Applied Biosystems) and specific primers, as previously described (Vinatzer et al., 2003). In Fig. S2, CD34+ progenitors cells either from controls or from patients were cultured in methylcellulose in the presence of SCF and various doses of G-CSF, or in the presence of SCF alone. Granulocytic colonies were counted 15 d later. Alternatively, cells from patients were cultured with or without 1 microM AZD1480. Fig. S3 indicates granulocytic differentiation using FACS analysis using anti-CD34, anti-CD15, anti-CD14, and anti-CD11b antibodies. Online supplemental material is available at .
###end p 42
###begin title 43
Supplementary Material
###end title 43
###begin title 44
[Supplemental Material]
###end title 44
###begin p 45
###xml 20 28 <span type="species:ncbi:9606">patients</span>
###xml 219 226 <span type="species:ncbi:9606">patient</span>
###xml 363 371 <span type="species:ncbi:9606">patients</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
We thank all of the patients and the controls who participated in the study, and AstraZeneca for the gift of the JAK2-specific inhibitor (AZD1480). We are grateful to Dr. N. Auger for performing cytogenetic analysis of patient 15, to Dr. C. Bellane-Chantelot for help in the genetic analysis of the pedigree, and to C. Preudhomme for providing us with samples of patients with neutrophilia. We also thank Dr. M. Ito for providing NOG mice.
###end p 45
###begin p 46
This work was supported by grants from the Ligue Nationale Contre le Cancer (equipe labelisee 2007), the Institut National du Cancer (INCa; projets libres 2007), the Laurette Fugain Association, and the Institut National de la Sante et de la Recherche Medicale. I. Plo received funds from INCa, Y. Zhang received funds from Medicen, and M. Nakatake received funds from la Ligue Nationale contre le Cancer.
###end p 46
###begin p 47
The authors declare no financial conflict of interest.
###end p 47
###begin article-title 48
Improved prediction for the structure of the dimeric transmembrane domain of glycophorin A obtained through global searching.
###end article-title 48
###begin article-title 49
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.
###end article-title 49
###begin article-title 50
New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition.
###end article-title 50
###begin article-title 51
###xml 69 74 <span type="species:ncbi:9606">human</span>
Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.
###end article-title 51
###begin article-title 52
A simple FISH assay for the detection of 3q26 rearrangements in myeloid malignancy.
###end article-title 52
###begin article-title 53
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin.
###end article-title 53
###begin article-title 54
###xml 108 116 <span type="species:ncbi:9606">patients</span>
An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia.
###end article-title 54
###begin article-title 55
Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey.
###end article-title 55
###begin article-title 56
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
###end article-title 56
###begin article-title 57
The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity.
###end article-title 57
###begin article-title 58
Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
###end article-title 58
###begin article-title 59
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
###end article-title 59
###begin article-title 60
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/gammac(null) (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells.
###end article-title 60
###begin article-title 61
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 196 203 <span type="species:ncbi:9606">patient</span>
Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
###end article-title 61
###begin article-title 62
Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.
###end article-title 62
###begin article-title 63
Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer.
###end article-title 63
###begin article-title 64
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia.
###end article-title 64
###begin article-title 65
An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia.
###end article-title 65
###begin p 66
Abbreviations used: G-CSF-R, G-CSF receptor; HSC, hematopoietic stem cell; MPD, myeloproliferative disorder; qRT-PCR, quantitative real-time PCR; SCF, stem cell factor; TM, transmembrane; TPO, thrombopoietin.
###end p 66

